Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type beta-lactamases

被引:37
作者
Canica, MM
Barthelemy, M
Gilly, L
Labia, R
Krishnamoorthy, R
Paul, G
机构
[1] HOP ROBERT DEBRE,INSERM U120,F-75019 PARIS,FRANCE
[2] NATL MUSEUM NAT HIST,CNRS URA 401,F-75231 PARIS,FRANCE
[3] UMR 175,F-29000 QUIMPER,FRANCE
关键词
D O I
10.1128/AAC.41.2.374
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
IRT-14 (TEM-45) is a new mutant TEM-type beta-lactamase that was isolated from clinical Escherichia coli P37 and that confers resistance to broad-spectrum penicillins with reduced sensitivity to beta-lactamase inhibitors, The MICs of amoxicillin alone and of amoxicillin combined with 2 mu g of clavulanic acid or 2 mu g of tazobactam per ml were 4,096, 2,048, and 1,024 mu g/ml, respectively. The strain was susceptible to cephalosporins, aztreonam, moxalactam, and imipenem, The enzyme was purified to homogeneity and values of the kinetic parameters k(cat), K-m, and k(cat)/K-m were determined for different substrates. This enzyme, with a pI of 5.2, was found to have reduced affinity for broad-spectrum penicillins and cephalosporins, The values of 50% inhibitory concentrations of clavulanic acid, sulbactam, tazobactam, and brobactam are correlated with the higher K(m)s for substrates, The resistance of E. coli P37 to mechanism-based inactivators results from a higher level of production of the TEM-derived enzyme due to the G-to-T substitution at position 162 (G-162-->T) in the promoter region of bla(TEM) and from the structural modifications resulting from the Met-69-->Leu and Arg-275-->Gln substitutions that characterize IRT-14 beta-lactamase.
引用
收藏
页码:374 / 378
页数:5
相关论文
共 37 条
  • [31] Sambrook J., 2002, MOL CLONING LAB MANU
  • [32] THE ASPARAGINE TO ASPARTIC-ACID SUBSTITUTION AT POSITION-276 OF TEM-35 AND TEM-36 IS INVOLVED IN THE BETA-LACTAMASE RESISTANCE TO CLAVULANIC ACID
    SAVES, I
    BURLETSCHILTZ, O
    SWAREN, P
    LEFEVRE, F
    MASSON, JM
    PROME, JC
    SAMAMA, JP
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (31) : 18240 - 18245
  • [33] INCIDENCE AND MECHANISMS OF RESISTANCE TO THE COMBINATION OF AMOXICILLIN AND CLAVULANIC ACID IN ESCHERICHIA-COLI
    STAPLETON, P
    WU, PJ
    KING, A
    SHANNON, K
    FRENCH, G
    PHILLIPS, I
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2478 - 2483
  • [34] NUCLEOTIDE-SEQUENCE OF AMPICILLIN RESISTANCE GENE OF ESCHERICHIA-COLI PLASMID PBR322
    SUTCLIFFE, JG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) : 3737 - 3741
  • [35] THOMSON CJ, 1992, FEMS MICROBIOL LETT, V91, P113
  • [36] VEDEL G, 1992, J ANTIMICROB CHEMOTH, V30, P449
  • [37] EMERGENCE OF CLINICAL ISOLATES OF ESCHERICHIA-COLI PRODUCING TEM-1 DERIVATIVES OR AN OXA-1 BETA-LACTAMASE CONFERRING RESISTANCE TO BETA-LACTAMASE INHIBITORS
    ZHOU, XY
    BORDON, F
    SIROT, D
    KITZIS, MD
    GUTMANN, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (05) : 1085 - 1089